Practical Management of Steroids in Non-Endocrine Practice

Similar documents
Corticosteroids. Abdulmoein Al-Agha, FRCPCH Professor of Pediatric Endocrinology, King Abdulaziz University Hospital,

Clinical Guideline. SPEG MCN Protocols Sub Group SPEG Steering Group

Assessing Adrenal Function in Ill, Hospitalized Patients. Bruce Redmon, MD Division of Endocrinology, Diabetes and Metabolism

Subclinical Problems in the ICU:

The analysis of Glucocorticoid Steroids in Plasma, Urine and Saliva by UPLC/MS/MS

WARD INSTRUCTIONS WEBSITE

Managing Addison s Disease

Cushing s Syndrome. Diagnosis. GuidelineCentral.com. Key Points. Diagnosis

Methylprednisolone iv to po dose

Trends in Glucocorticoid-Induced Osteoporosis Management Among Seniors in Ontario,

Audit of Adrenal Function Tests. Kate Davies Senior Lecturer in Children s Nursing London South Bank University London, UK

Agreed Core Safety Profile for Budesonide nasal spray suspension and Budesonide nasal powder

PRESCRIBING INFORMATION

A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy

Endocrine Emergencies: Recognition and Management

Dr John Quin. Royal Sussex County Hospital, Brighton. BHIVA AUTUMN CONFERENCE 2013 Including CHIVA Parallel Sessions. None

Cortisol levels. Naturally produced by the adrenal Cortisol

Cortisol (serum, plasma)

DIAGNOSING AND TREATING CORTISOL INSUFFICIENCY IN ICU MOHD BASRI MAT NOR, IIUM, KUANTAN, MALAYSIA

NOTTINGHAM UNIVERSITY HOSPITAL NHS TRUST: Clinical Chemistry Guidelines

The endocrine system is made up of a complex group of glands that secrete hormones.

Insulin Tolerance Test Protocol - RNS Endocrinology

THE VALUE OF 24 HOUR PROFILES IN ASSESSING CORTISOL REPLACEMENT IN HYPOPITUITARISM

ADDISON S DISEASE THE FACTS YOU NEED TO KNOW

Diabetes and steroids: Storm conditions

Glucocorticoid replacement, Steroids, Acute Illness Dr Rupa Ahluwalia, Consultant Physician (NNUH)

Core Safety Profile. Pharmaceutical form(s)/strength: Dry Powder Inhaler, Nebuliser Suspension, pressurised Metered Dose Inhaler (pmdi)

Mineralocorticoids: aldosterone Angiotensin II/renin regulation by sympathetic tone; High potassium will stimulate and ACTH Increase in aldosterone

Conversion of iv hydrocortisone to oral

THE ENDOCRINE SYSTEM Station 1 (A)

Sajeev Menon MD ADRENAL INSUFFICIENCY? FATIGUE? OUTLINE OBJECTIVES PATIENT 1 PATIENT 1 : CLINICAL COURSE

Glucocoricoid replacement in pituitary disease. Are we getting this right? Karim Meeran 23 rd May 2018

Pharmacology of Corticosteroids

Endocrine part one. Presented by Dr. Mohammad Saadeh The requirements for the Clinical Chemistry Philadelphia University Faculty of pharmacy

Differential Diagnosis of Cushing s Syndrome

Recommendations differ slightly in defining a suppressed patient, but general guidelines are below (Table 1):

Steroid replacement advice. Information for patients Endocrinology

Package leaflet: Information for the patient. Dexametason Abcur 4 mg tablets. Dexamethasone

Corticosteroids. Hawler Medical University College of Medicine Department of Pharmacology and Biophysics Dr.Susan Abdulkadir Farhadi MSc Pharmacology

Adrenal Gland Disorders

Steroid withdrawal in polymyalgia rheumatica: the theory versus the practice

LOVE YOUR BONES Protect your future

Objectives. Pathophysiology of Steroids. Question 1. Pathophysiology 3/1/2010. Steroids in Septic Shock: An Update

Adrenal Ganglioneuroma Presenting With Adrenal Insufficiency After Unilateral Adrenalectomy

Patient Group Direction for PREDNISOLONE (Version 02) Valid From 1 October September 2019

Corticosteroids รศ. พญ. มาล ยา มโนรถ. Corticosteroids ภาคว ชาเภส ชว ทยา จ ดประสงค การศ กษา

STEROIDS IN GENERAL PRACTICE

Summary of Product Characteristics

CUSHING SYNDROME Dr. Muhammad Sarfraz

Diurnal Group plc. Analyst Day 11 December Date of Preparation: December 2018 Code: CORP-GB-0023

ASY-857.1: Synacthen Stimulated 17OH-progesterone Test

355 Lexington Avenue, 15th Floor New York, NY (Helpline) fax

Shortness of breath prednisone tapering

In memory of Thomas Addison M.D. Son of Joseph and Sarah Addison. Died June 29th 1860 aged 66 years. For 36 years physician to Guy s Hospital London.

Insulin Initiation, titration & Insulin switch in the Primary Care-KISS

CUSHING S SYNDROME THE FACTS YOU NEED TO KNOW

FLOMIST Aqueous Nasal Spray (Fluticasone propionate)

PRODUCT LEAFLET: USER INFORMATION HYDROCORTISONE ERFA 20 MG TABLETS. Hydrocortisone

Chiara Simeoli. Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia Università Federico II di Napoli

Pituitary Gland Disorders

Lawrence S. Kirschner, MD, PhD Professor of Medicine

Adrenal Pharmacology

Prednisone tapering schedule 60 mg

Please inform the Diabetes Nurse Specialist that this patient has been admitted within 24hrs of admission.

MILD HYPERCORTISOLISM DUE TO ADRENAL ADENOMA: IS IT REALLY SUBCLINICAL?

Managing Hyperglycaemia in Acute (Adult) Inpatients Requiring Enteral Feeding Guidelines

Cushing s syndrome and adrenal insufficiency

SUMMARY OF PRODUCT CHARACTERISTICS

TEMSIROLIMUS in renal cell cancer

Female Reproductive Endocrinology

THE VALUE OF 24 HOUR PROFILES IN CONGENITAL ADRENAL HYPERPLASIA

Acute painful crisis in patients with sickle cell disease: Clinical Guidelines (HN-506a)

The adrenal gland consists of the cortex & the medulla. Medulla secretes epinephrine, whereas cortex synthesizes & secretes two major classes of

The Adrenals Are a key factor in all hormonal issues Because the adrenals can convert one hormone to another they play a role like no other in the bod

FURAMIST Nasal Spray (Fluticasone furoate )

Endocrinology for Finals. Maralyn Druce Professor of Endocrine Medicine Barts and the London School of Medicine

To Stress or Not.. Considerations for perioperative steroid stress dosing. Matthew Loftus, BSN, RN, CFRN, PHRN, SRNA Allegheny School of Anesthesia

Case Finding and Risk Assessment for Osteoporosis

All Wales Paediatric Steroid Replacement Therapy Card

Budesonide prednisone equivalent

C h a p t e r 3 8 Cushing s Syndrome : Current Concepts in Diagnosis and Management

Executive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules)

Osteoporosis Screening and Treatment in Type 2 Diabetes

SNOMED CT Induced Classifications

ASTHMA TREATMENT AND THE HPA AXIS

MANAGEMENT OF DIABETES IN PREGNANCY

Ahmed Al Nahari Pediatric Endocrinology Fellow March 11,2016

Package leaflet: Information for the patient. Plenadren 5 mg modified-release tablets Plenadren 20 mg modified-release tablets Hydrocortisone

Pharmacology Adrenal Steroids. Adrenal steroids. Dr. Ahmad Al-Zohyri. Dr. Ahmad Al-Zohyri Lec. 10

TOPCORT Cream/Ointment (Mometasone furoate 0.1%)

Subclinical Cushing s Syndrome

Osteoporosis: fragility fracture risk. Costing report. Implementing NICE guidance

PRESCRIBING INFORMATION. (betamethasone sodium phoshate) Enema 5 mg/100 ml. Topical Corticosteroid

Cushingoid facies from one time intra-articular joint kenalog injection

Emflaza. (deflazacort) New Product Slideshow

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Giant Cell Arteritis Protocol

UNUSUAL CAUSE OF ADRENAL INSUFFICIENCY. Dr.Khushboo Dr.S.Balasubramanian s unit

Application for Endorsement of CQI (Clinical Audit) Activities for MOPS Credits Allocation

Transcription:

Practical Management of Steroids in Non-Endocrine Practice Dr Miguel Debono MD MRCP PhD Consultant Physician in Endocrinology and Honorary Senior Lecturer February 2016

Outline Epidemiology of steroids Case Presentation 1 o o o General management of steroids Glucocorticoid induced osteoporosis Glucocorticoid induced hyperglycaemia Case Presentation 2 o o Glucocorticoid induced adrenal suppression Adrenal crisis and sick day rules

Prevalence of use % Epidemiology of Steroid Use N = 244, 235 Women < 2.5mg 2.5 7.5mg > 7.5mg Men INDICATION % Respiratory System 39.9% Skin and subcutaneous tissue Musculoskeletal and connective tissue 6.2% 6.2% Nervous System 3.4% Digestive system 2.8% Neoplasms 2.3% Circulatory system 1.9% Injury & poisoning 1.3% Unknown 20.4% Age (years) Van Staa TP et al, Q J Med 2000; 93:105-111

Properties and dose equivalents to HC Corticosteroid Approx equivalent dose (mg) Relative glucocorticoid effect Relative mineralocorticoid effect Duration of effect (hours) Hydrocortisone 20 1 1 8 12 Cortisone 25 0.8 0.8 8 12 Prednisolone 5 4 0.8 12 36 Methyl prednisolone 4 5 Minimal 12 36 Dexamethasone 0.75 30 Minimal 36 72 Betamethasone 0.6 30 Negligible 36 72 Fludrocortisone 0.05 0.1 10-15 125-150 12 36

Adverse effects related to cumulative dose N = 2167 SE were common affecting at least 90% of subjects Q1: <1.7g Q2: 1.7 2.8g Q3: 2.9 4.7g Q4: >4.7g * Also related to low dose <7.5mg/day prednisolone Sleep probs* Acne* Skin bruising/ thinning* Weight gain* Mood probs Cataracts* High blood glucose Bone fractures* Curtis et al Arthritis and Rheumatism 2006 55: 420-426

Adverse effects related to daily dose Linear effect <5mg to >7.5mg Cushingoid phenotype Ecchymosis Leg oedema Thin skin Sleep disturbances Fractures Threshold effect Low Dose (~ <5 7.5mg/day Pred) Eye cataract Adrenal suppression High dose (~ >5 7.5mg/day Pred) Epistaxis Weight gain Low BMD Infections High blood glucose Depression Glaucoma Increased blood pressure CV events Myopathy Psychiatric disturbances Mortality

Case Presentation 1 Dear Physician, I would be really grateful if you could see this patient who has been diagnosed with polymyalgia rheumatica and who is to start long term steroids. Your advice how to manage her steroids will be appreciated. She is concerned about side effects. Thanks for your help

Monitoring patients on steroids Baseline Before starting or on first assessment History including total dose, date of initiation Weight, height, BMI, blood pressure FBC, Fasting blood glucose/hba1c ±OGTT, Lipid profile, BMD Continuation Follow up Annual height, enquire for fracture, BMD 1 year post GC initiation then every 2 to 3 years, assess for joint pain Consider lateral spine X-ray in adults >65 years and FRAX Assess CV risk, measure lipids, BP every 6 to 12 months Screen for diabetes during first 48 hours, every 3 to 6 months, then annually Annual ophthalmic assessment for cataracts and glaucoma

General advice to patients on steroids Prescribe the lowest effective dose for the shortest period of time Treat pre-existing co-morbid conditions and use GC sparing agents Sick day rules, steroid card Lifestyle recommendations exercise, healthy diet, no smoking Avoid contact with infectious people and warn about pregnancy risks DO NOT STOP steroids abruptly

Drug interactions Drugs that impair metabolism by inhibition of Cytochrome P450 3A4 o o o o Anti-fungals Antibiotics e.g macrolides Antivirals e.g indinavir, ritonavir Fluoxetine, diltiazem, cimetidine Drugs that accelerate metabolism by induction of Cytochrome P450 3A4 o o Anticonvulsants e.g carbamazepine, phenytoin, phenobarbital Rifampicin, Pioglitazone Drugs that increase CBG and may falsely elevate cortisol results o Oestrogens, mitotane

Fracture Risk Depends on the Dose of Glucocorticoids Relative risk of fracture 6 5 4 3 Hip Vertebral 2 1 0 2.5 mg/d 2.5-7.5 mg/d >7.5 mg/d Adapted from Van Staa TP et al, J Bone Miner Res 2000;15(6) 993-1000

Guidelines for GCinduced osteoporosis

Burt et al JCEM 2011; 96: 1789-1796 Glucocorticoid-induced hyperglycaemia N=7 N=40 N=13

Adopted from JBDS Management of Hyperglycaemia and Steroid Therapy Management of glucocorticoid induced hyperglycaemia - once daily dosing Monitor BG in patients on steroids If BG >12mmol/l on two occasions pre or post meals, to start gliclazide 40mg/day (to a maximum of 240mg) If BG still >12mmol/l pre or post meals, consider 10 units basal human insulin preferably (NPH, Humulin I) or if persistent hyperglycaemia throughout day use basal insulin analogue Adjust doses by 10 to 20% on a daily basis; adjust dose when steroid doses decreasing

Adopted from JBDS Management of Hyperglycaemia and Steroid Therapy Management of glucocorticoid induced hyperglycaemia - multiple daily dosing Monitor BG in patients on steroids If BG >12mmol/l on two occasions pre or post meals, to start gliclazide 40mg bd (max 160mg bd) If BG still >12mmol/l pre or post meals, consider basal, twice daily premixed or basal-bolus Adjust doses by 10 to 20% on a daily basis; adjust dose when steroid doses decreasing

Case Presentation 2 Dear Endocrinologist, I would be grateful if you could see and advise about the possibility of getting this patient off steroids. She is 45y with difficult asthma but has been exacerbation free for the last 24 months, and is only on steroids. Her BMD shows osteopaenia and is keen to see if she can be free of steroids. Best wishes, Etc.

Case Presentation 2 45y Asthma since 16y On oral prednisolone for last 15 years Never on less than prednisolone 5mg Very keen to come off oral prednisolone Examination mild Cushing s

Case Presentation 2 What is the likelihood that she has endogenous cortisol production? Assuming the asthma does not flare what are the chances of getting her off steroids? At what rate should the steroids be reduced?

Suppression of HPA axis ACTH Cortisol Exogenous glucocorticoids suppress HPA axis

Cortisol (nmol/l) Debono et al., JCEM 2009 94: 1548-1554 Cortisol Circadian Rhythm 600 500 400 Acrophase: 0832h (0759h - 0905h) 300 200 Nadir: 0018h (2339h 0058h) 100 MESOR: 143.6 nmol/l (130.1-156.1) 0 22 23 24 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Clock Time

Steroid withdrawal protocol following long-term glucocorticoids Discuss with patient about goals Convert to prednisolone 5 to 7.5mg OD Reduce by 1mg every 1-2 months Monitor symptoms Monitor HPA status at prednisolone 3mg/day If inflammatory disease worsens and/or has another flare up - may be better to accept long-term glucocorticoids Consider alternate day dosing

Dec-04 Jan-05 Feb-05 Mar-05 Apr-05 May-05 Jun-05 Jul-05 Aug-05 Sep-05 Oct-05 Nov-05 Dec-05 Jan-06 Feb-06 Mar-06 Apr-06 May-06 Jun-06 Jul-06 Aug-06 Sep-06 Case 2 - Recovery of HPA axis Cortisol nm 700 600 500 400 300 200 100 Prednisolone 4mg 3mg 2mg 1mg Pass on synacthen test ACTH Normal range ACTH 30 minute cortisol basal cortisol 80 70 60 50 40 30 20 10 ACTH pg/ml 0 0 Also see Graber et al JCEM 1965; 25: 11 16

Assay cross reactivity Cross reactivity of exogenous glucocorticoid with serum cortisol immunoassay Hydrocortisone - 100% Cortisone acetate - up to 100% Prednisolone - up to 30% Prednisone - up to 30% Dexamethasone - zero

Does this patient on steroids have tertiary adrenal insufficiency? Confirm patient on treatment glucocorticoids and record history When on pred dose equiv 3mg measure 9am serum cortisol and ACTH Cortisol <100nmol/L or <150nmol/L and ACTH <10pg/mL Cortisol100nmol/L (or 150nmol/L & ACTH >10pg/mL) 350nmol/L Cortisol >350nmol/L Inhaled, nasal or topical start HC replacement, ask referral team to adjust GC dose, sick day rules Oral, intra-articular or intramuscular ask referral team to? adjust GC dose, sick day rules, rescue steroids No im or iv 250µg Synacthen test 30min se cortisol >550nmol/L Yes No change unless symptoms of AI

Sick Day Rules Extra steroid cover during acute illness, trauma or surgery Double the normal daily steroid dose when patient has a temperature > 37.5 o C If vomits/diarrhoea should take 5mg prednisolone equiv equiv immediately after and sip electrolyte fluids Severe illness (temp > 40 o C or repetitive vomiting / diarrhoea) ask for medical help, administer 100mg HC im and hospital assessment Steroid cover is needed in surgery and labour

Addisonian Emergency Crisis Immediate samples for cortisol and ACTH Intravenous N. Saline Hydrocortisone 100mg im 6 hourly until eating and drinking (Both saline and HC as soon as blood test taken do not wait for result) Treat precipitant e.g infection When resolving convert to double oral steroid dose for 2 to 3 days, then back to normal treatment

Conclusion Steroids are highly effective drugs, essential and life saving Unfortunately they can result in side effects impacting on patient health and quality of life Careful monitoring for adverse effects, prophylactic measures and early treatment may reduce patient morbidity When in doubt about HPA status refer patient to endocrinology